Biotech - IoT Digital Twin PLM

In-Vivo CAR-T Cell Therapy: How Engineering T-Cells Inside the Body Works (2026)

By MPRAUTO MPRAUTO July 2, 2026ScienceNo Comments

How in-vivo CAR-T cell therapy works: engineering T-cells inside the body with lipid nanoparticles and targeted vectors, versus ex-vivo manufacturing, and the 2026 pipeline.

Optogenetics: Engineering Light-Controlled Neurons

By MPRAUTO MPRAUTO June 28, 2026ScienceNo Comments

How optogenetics works: opsins like channelrhodopsin, light delivery, viral targeting, and how engineered light-controlled neurons are decoding the brain in 2026.

Xenotransplantation: Engineering Pig Organs for Humans

By MPRAUTO MPRAUTO June 27, 2026Science1 Comment

How xenotransplantation works in 2026: CRISPR gene-edited pig organs, immune rejection, PERV knockout, and the engineering behind cross-species transplants.

AI Protein Design: How RFdiffusion Generates New Proteins (2026)

By MPRAUTO MPRAUTO June 24, 2026ScienceNo Comments

How generative AI designs proteins from scratch: the RFdiffusion denoising pipeline, ProteinMPNN sequence design, AlphaFold validation, and wet-lab loop.

How CAR-T Cell Therapy Actually Works (2026)

By MPRAUTO MPRAUTO June 20, 2026Tech1 Comment

How CAR-T cell therapy works in 2026: the chimeric antigen receptor, the manufacturing loop, why solid tumors resist, and the move toward in vivo CAR-T.

Brain Organoid Biocomputing Explained (2026)

By MPRAUTO MPRAUTO June 17, 2026ScienceNo Comments

How brain organoid biocomputing works in 2026: culturing neural organoids, electrode interfaces, training signals, and the honest limits of wetware compute.

Cryo-EM Meets AI: Structure Prediction in Drug Discovery

By MPRAUTO MPRAUTO June 6, 2026ScienceNo Comments

How cryo-EM and AI structure prediction work together in 2026 drug discovery — the pipeline, what AlphaFold-class models add, and the honest limitations.

mRNA Beyond Vaccines: Programmable Therapeutics Explained

By MPRAUTO MPRAUTO May 25, 2026ScienceNo Comments

mRNA beyond vaccines — how programmable therapeutics work, lipid nanoparticle delivery, the manufacturing platform, and the real limits today.

AlphaFold 3 and Protein Structure Prediction Explained

By MPRAUTO MPRAUTO May 24, 2026ScienceNo Comments

AlphaFold 3 explained — how the diffusion-based model predicts protein, DNA, and ligand structures, why it matters, and its real limitations.

Cell-Free Biomanufacturing: Engineering Protein Production Without Living Cells

By MPRAUTO MPRAUTO April 16, 2026ScienceNo Comments

How cell-free biomanufacturing systems produce proteins and enzymes without living organisms. TX-TL systems, lysate preparation, reaction engineering, and industrial scale-up challenges.